Literature DB >> 2659540

Marker profile of mesothelial cells versus ovarian carcinoma cells.

C C van Niekerk1, P H Jap, C M Thomas, D F Smeets, F C Ramaekers, L G Poels.   

Abstract

We investigated the marker profile of human ascitic and cultured mesothelial cells, and compared it to that of ovarian carcinoma cells which are related in terms of their histogenesis, unrelated colon carcinomas being used as reference. Mesothelial and ovarian carcinoma cells could not be distinguished by (intermediate) filament typing, using monoclonal antibodies (MAbs) to keratins, vimentins and desmins. Colon carcinomas differed from mesothelial cells and ovarian carcinomas by the absence of keratin-7 filaments. The epithelial marker BW 495/36 was completely negative on mesothelial cells and positive on all ovarian and colon carcinoma cells. While CEA was found on about 85% of all colon carcinomas, CEA expression on mesothelial cells and ovarian carcinoma cells was below 20%. The ovarian carcinoma markers (OV-TL 3, OV-TL 10, OC 125, MOV 18) were strongly positive on ovarian carcinomas and negative on colon carcinomas (or limited to traces of immunofluorescence on some samples). Although the mesothelial cells showed weak or negative reactivity with these markers, OC 125 antigen was found by immunoelectron microscopy on the surface of cultured mesothelial cells, and was shed in the culture supernatant at concentrations of 50, 28, and 25 CA 125 U/ml/10(4) positive cells. This suggests that mesothelial cells may be responsible for the synthesis of CA 125 in ascitic fluid. The data indicate that ovarian carcinomas, mesothelial cells and colon carcinomas can be distinguished using a combination of anti-keratin antibodies with BW 495/36 and anti-ovarian carcinoma markers.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2659540     DOI: 10.1002/ijc.2910430619

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Cytogenetic, morphologic and oncogene analysis of a cell line derived from a heterologous mixed mullerian tumor of the ovary.

Authors:  J L Becker; P R Papenhausen; R H Widen
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-05       Impact factor: 2.416

2.  Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas.

Authors:  F Ramaekers; C van Niekerk; L Poels; E Schaafsma; A Huijsmans; H Robben; G Schaart; P Vooijs
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

3.  The OV-TL 12/30 clone of anti-cytokeratin 7 antibody as a new marker of corneal conjunctivalization in patients with limbal stem cell deficiency.

Authors:  Katerina Jirsova; Lubica Dudakova; Sarka Kalasova; Viera Vesela; Stanislava Merjava
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-29       Impact factor: 4.799

4.  Changes in expression of differentiation markers between normal ovarian cells and derived tumors.

Authors:  C C Van Niekerk; F C Ramaekers; A G Hanselaar; J Aldeweireldt; L G Poels
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

5.  Marker profile of different phases in the transition of normal human ovarian epithelium to ovarian carcinomas.

Authors:  C C van Niekerk; O C Boerman; F C Ramaekers; L G Poels
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

6.  Establishment of an immortalised human ovarian surface epithelial cell line without chromosomal instability.

Authors:  T Maeda; H Tashiro; H Katabuchi; M Begum; H Ohtake; T Kiyono; H Okamura
Journal:  Br J Cancer       Date:  2005-07-11       Impact factor: 7.640

7.  Establishment, characterization and downstream application of primary ovarian cancer cells derived from solid tumors.

Authors:  Thanasak Sueblinvong; Rahel Ghebre; Yoshie Iizuka; Stefan E Pambuccian; Rachel Isaksson Vogel; Amy P N Skubitz; Martina Bazzaro
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

8.  Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells.

Authors:  N Jonjić; G Peri; S Bernasconi; F L Sciacca; F Colotta; P Pelicci; L Lanfrancone; A Mantovani
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

9.  Is an increase in CA 125 in breast cancer patients an indicator of pleural metastases?

Authors:  W Jäger; A Kissing; S Cilaci; R Melsheimer; N Lang
Journal:  Br J Cancer       Date:  1994-09       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.